EMEA-003313-PIP03-23 - paediatric investigation plan
povorcitinib
PIPHuman
Key facts
- Active Substance
- povorcitinib
- Therapeutic area
- Skin and subcutaneous tissue disorders
- Decision number
- P/0096/2024
- PIP number
- EMEA-003313-PIP03-23
- Pharmaceutical form(s)
- Tablet
- Condition(s) / indication(s)
- Treatment of prurigo nodularis
- Route(s) of administration
- Oral use
- Contact for public enquiries
Incyte Biosciences Distribution B.V.
E-mail: RA@incyte.com
- Decision type
- W: decision granting a waiver in all age groups for all conditions or indications
- Decision date